Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$63,000.00

Characterization of a glycoprotein entry complex from a novel orthomyxovirus

FY 2016-17

Summary
Infectious salmon anaemia virus (ISAV) is a significant emerging disease of Atlantic farmed salmon that causes severe anemia. The disease can progress slowly throughout an infected farm, and mortality rates may approach 100%. The virus was first identified in Norway in 1984, but over the last 25 years ISAV has caused major disease outbreaks in Canada, U.S., and other countries around the world. In July 2012, a confirmed outbreak in Newfoundland prompted the destruction of 450,000 farmed salmon. The virus has caused major economic losses and is a major threat to the viability of salmon farming. Currently, very little is known about its viral lifecycle. Additional studies are urgently needed to understand the basic biology of how this virus enters its salmon host.ISAV is a negative-strand, segmented ssRNA virus in the orthomyxovirus family, similar to human influenza virus A. The virus displays two surface glycoproteins that are involved in its entry: (a) a 42 kDa hemagglutinin-esterase (HE) that is responsible for receptor engagement, tropism and receptor destruction/release; and (b) a 50 kDa F glycoprotein with fusion activity. These two proteins are critical to the ISAV lifecycle and pathogenesis. ISAV is the only known member of the orthomyxovirus family with attachment and fusion activities on different proteins, and understanding this process offers a unique opportunity to contribute new model principles. Using a combination of tried-and-true, as well as innovative biophysical approaches, we aim to determine the molecular determinants of: (1) ISAV HE-mediated receptor binding and release, and (2) ISAV F-mediated fusion. Structural and functional studies of viral glycoproteins warrant a significant effort as the results will be critical to our atomic-level understanding of ISAV attachment, entry and pathogenesis. Moreover, any structural models obtained will deliver a molecular blueprint for the development of novel preventative strategies.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
435607-2013
Name nom
Lee, Jeffrey
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2013
Award amount
63000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
4
Nb partie
5
Application title
Characterization of a glycoprotein entry complex from a novel orthomyxovirus
Keyword
NSERC
Application summary
Infectious salmon anaemia virus (ISAV) is a significant emerging disease of Atlantic farmed salmon that causes severe anemia. The disease can progress slowly throughout an infected farm, and mortality rates may approach 100%. The virus was first identified in Norway in 1984, but over the last 25 years ISAV has caused major disease outbreaks in Canada, U.S., and other countries around the world. In July 2012, a confirmed outbreak in Newfoundland prompted the destruction of 450,000 farmed salmon. The virus has caused major economic losses and is a major threat to the viability of salmon farming. Currently, very little is known about its viral lifecycle. Additional studies are urgently needed to understand the basic biology of how this virus enters its salmon host.ISAV is a negative-strand, segmented ssRNA virus in the orthomyxovirus family, similar to human influenza virus A. The virus displays two surface glycoproteins that are involved in its entry: (a) a 42 kDa hemagglutinin-esterase (HE) that is responsible for receptor engagement, tropism and receptor destruction/release; and (b) a 50 kDa F glycoprotein with fusion activity. These two proteins are critical to the ISAV lifecycle and pathogenesis. ISAV is the only known member of the orthomyxovirus family with attachment and fusion activities on different proteins, and understanding this process offers a unique opportunity to contribute new model principles. Using a combination of tried-and-true, as well as innovative biophysical approaches, we aim to determine the molecular determinants of: (1) ISAV HE-mediated receptor binding and release, and (2) ISAV F-mediated fusion. Structural and functional studies of viral glycoproteins warrant a significant effort as the results will be critical to our atomic-level understanding of ISAV attachment, entry and pathogenesis. Moreover, any structural models obtained will deliver a molecular blueprint for the development of novel preventative strategies.